Margaret Favata Selected Research

Proteins (Proteins, Gene)

1/2019

The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Margaret Favata Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 01/2010
2	Multiple Myeloma 01/2019 - 01/2010
1	Arthritis (Polyarthritis) 10/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2020
1	Colitis 10/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018
1	Bone Resorption 04/2007
1	Postmenopausal Osteoporosis 04/2007

Drug/Important Bio-Agent (IBA)

2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2020
2	Janus KinasesIBA 01/2019 - 01/2010
1	itacitinibIBA 10/2020
1	growth arrest-specific protein 6IBA 01/2020
1	c-Mer Tyrosine KinaseIBA 01/2020
1	pervanadateIBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	INCB054329IBA 01/2019
1	InterleukinsIBA 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018
1	Bendamustine Hydrochloride FDA Link 01/2018
1	CytokinesIBA 01/2010
1	INCB 16562IBA 01/2010
1	Interleukin-6 (Interleukin 6)IBA 01/2010
1	Amino Acids FDA Link 04/2007
1	Parathyroid Hormone (Parathormone)IBA 04/2007
1	Peptides (Polypeptides)IBA 04/2007

Therapy/Procedure

1	Cannula 10/2020
1	Therapeutics 01/2018